Suvi Sippola1,2, Jussi Haijanen1,2,3, Juha Grönroos1,2, Tero Rautio4,5, Pia Nordström6,7, Tuomo Rantanen8,9, Tarja Pinta10, Imre Ilves11, Anne Mattila12, Jukka Rintala4,13, Eliisa Löyttyniemi14, Saija Hurme14, Ville Tammilehto15, Harri Marttila16, Sanna Meriläinen4,5, Johanna Laukkarinen6,7, Eeva-Liisa Sävelä3, Heini Savolainen8, Tomi Sippola10, Markku Aarnio12, Hannu Paajanen11, Paulina Salminen1,2. 1. Division of Digestive Surgery and Urology, Turku University Hospital, Turku, Finland. 2. Department of Surgery, University of Turku, Turku, Finland. 3. Department of Surgery, Satakunta Central Hospital, Pori, Finland. 4. Department of Surgery, Oulu University Hospital, Oulu, Finland. 5. Medical Research Center Oulu, University of Oulu, Finland. 6. Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere, Finland. 7. Faculty of Medicine and Health Technology, University of Tampere, Tampere, Finland. 8. Department of Surgery, Kuopio University Hospital, Kuopio, Finland. 9. Department of Surgery, Institute of Clinical Medicine, University of Eastern Finland. 10. Department of Surgery, Seinäjoki Central Hospital, Seinäjoki, Finland. 11. Department of Surgery, Mikkeli Central Hospital, Mikkeli, Finland. 12. Department of Surgery, Jyväskylä Central Hospital, Jyväskylä, Finland. 13. Department of Surgery, Rovaniemi Central Hospital, Rovaniemi, Finland. 14. Department of Biostatistics, University of Turku, Turku, Finland. 15. Department of Radiology, Turku University Hospital, Turku, Finland. 16. Department of Hospital Hygiene & Infection Control, Turku University Hospital, Turku, Finland.
Abstract
Importance: Antibiotics are an effective and safe alternative to appendectomy for managing uncomplicated acute appendicitis, but the optimal antibiotic regimen is not known. Objective: To compare oral antibiotics with combined intravenous followed by oral antibiotics in the management of computed tomography-confirmed uncomplicated acute appendicitis. Design, Setting, and Participants: The Appendicitis Acuta (APPAC) II multicenter, open-label, noninferiority randomized clinical trial was conducted from April 2017 until November 2018 in 9 Finnish hospitals. A total of 599 patients aged 18 to 60 years with computed tomography-confirmed uncomplicated acute appendicitis were enrolled in the trial. The last date of follow-up was November 29, 2019. Interventions: Patients randomized to receive oral monotherapy (n = 295) received oral moxifloxacin (400 mg/d) for 7 days. Patients randomized to receive intravenous antibiotics followed by oral antibiotics (n = 288) received intravenous ertapenem (1 g/d) for 2 days followed by oral levofloxacin (500 mg/d) and metronidazole (500 mg 3 times/d) for 5 days. Main Outcomes and Measures: The primary end point was treatment success (≥65%) for both groups, defined as discharge from hospital without surgery and no recurrent appendicitis during 1-year follow-up, and to determine whether oral antibiotics alone were noninferior to intravenous and oral antibiotics, with a margin of 6% for difference. Results: Among 599 patients who were randomized (mean [SD] age, 36 [12] years; 263 [44%] women), 581 (99.7%) were available for the 1-year follow-up. The treatment success rate at 1 year was 70.2% (1-sided 95% CI, 65.8% to ∞) for patients treated with oral antibiotics and 73.8% (1-sided 95% CI, 69.5% to ∞) for patients treated with intravenous followed by oral antibiotics. The difference was -3.6% ([1-sided 95% CI, -9.7% to ∞]; P = .26 for noninferiority), with the confidence limit exceeding the noninferiority margin. Conclusion and Relevance: Among adults with uncomplicated acute appendicitis, treatment with 7 days of oral moxifloxacin compared with 2 days of intravenous ertapenem followed by 5 days of levofloxacin and metronidazole resulted in treatment success rates greater than 65% in both groups, but failed to demonstrate noninferiority for treatment success of oral antibiotics compared with intravenous followed by oral antibiotics. Trial Registration: ClinicalTrials.gov Identifier: NCT03236961; EudraCT Identifier: 2015-003633-10.
Importance: Antibiotics are an effective and safe alternative to appendectomy for managing uncomplicated acute appendicitis, but the optimal antibiotic regimen is not known. Objective: To compare oral antibiotics with combined intravenous followed by oral antibiotics in the management of computed tomography-confirmed uncomplicated acute appendicitis. Design, Setting, and Participants: The Appendicitis Acuta (APPAC) II multicenter, open-label, noninferiority randomized clinical trial was conducted from April 2017 until November 2018 in 9 Finnish hospitals. A total of 599 patients aged 18 to 60 years with computed tomography-confirmed uncomplicated acute appendicitis were enrolled in the trial. The last date of follow-up was November 29, 2019. Interventions: Patients randomized to receive oral monotherapy (n = 295) received oral moxifloxacin (400 mg/d) for 7 days. Patients randomized to receive intravenous antibiotics followed by oral antibiotics (n = 288) received intravenous ertapenem (1 g/d) for 2 days followed by oral levofloxacin (500 mg/d) and metronidazole (500 mg 3 times/d) for 5 days. Main Outcomes and Measures: The primary end point was treatment success (≥65%) for both groups, defined as discharge from hospital without surgery and no recurrent appendicitis during 1-year follow-up, and to determine whether oral antibiotics alone were noninferior to intravenous and oral antibiotics, with a margin of 6% for difference. Results: Among 599 patients who were randomized (mean [SD] age, 36 [12] years; 263 [44%] women), 581 (99.7%) were available for the 1-year follow-up. The treatment success rate at 1 year was 70.2% (1-sided 95% CI, 65.8% to ∞) for patients treated with oral antibiotics and 73.8% (1-sided 95% CI, 69.5% to ∞) for patients treated with intravenous followed by oral antibiotics. The difference was -3.6% ([1-sided 95% CI, -9.7% to ∞]; P = .26 for noninferiority), with the confidence limit exceeding the noninferiority margin. Conclusion and Relevance: Among adults with uncomplicated acute appendicitis, treatment with 7 days of oral moxifloxacin compared with 2 days of intravenous ertapenem followed by 5 days of levofloxacin and metronidazole resulted in treatment success rates greater than 65% in both groups, but failed to demonstrate noninferiority for treatment success of oral antibiotics compared with intravenous followed by oral antibiotics. Trial Registration: ClinicalTrials.gov Identifier: NCT03236961; EudraCT Identifier: 2015-003633-10.
Authors: N de Korte; J Ph Kuyvenhoven; D L van der Peet; R J Felt-Bersma; M A Cuesta; H B A C Stockmann Journal: Colorectal Dis Date: 2012-03 Impact factor: 3.788
Authors: Johan Styrud; Staffan Eriksson; Ingemar Nilsson; Gunnar Ahlberg; Staffan Haapaniemi; Gunnar Neovius; Lars Rex; Ibrahim Badume; Lars Granström Journal: World J Surg Date: 2006-06 Impact factor: 3.352
Authors: Paulina Salminen; Hannu Paajanen; Tero Rautio; Pia Nordström; Markku Aarnio; Tuomo Rantanen; Risto Tuominen; Saija Hurme; Johanna Virtanen; Jukka-Pekka Mecklin; Juhani Sand; Airi Jartti; Irina Rinta-Kiikka; Juha M Grönroos Journal: JAMA Date: 2015-06-16 Impact factor: 56.272
Authors: Mauro Podda; Chiara Gerardi; Nicola Cillara; Nicola Fearnhead; Carlos Augusto Gomes; Arianna Birindelli; Andrea Mulliri; Richard Justin Davies; Salomone Di Saverio Journal: Ann Surg Date: 2019-12 Impact factor: 12.969
Authors: L Daniels; Ç Ünlü; N de Korte; S van Dieren; H B Stockmann; B C Vrouenraets; E C Consten; J A van der Hoeven; Q A Eijsbouts; I F Faneyte; W A Bemelman; M G Dijkgraaf; M A Boermeester Journal: Br J Surg Date: 2016-09-30 Impact factor: 6.939
Authors: S Sippola; J Grönroos; R Tuominen; H Paajanen; T Rautio; P Nordström; M Aarnio; T Rantanen; S Hurme; P Salminen Journal: Br J Surg Date: 2017-07-05 Impact factor: 6.939
Authors: Joseph S Solomkin; John E Mazuski; John S Bradley; Keith A Rodvold; Ellie J C Goldstein; Ellen J Baron; Patrick J O'Neill; Anthony W Chow; E Patchen Dellinger; Soumitra R Eachempati; Sherwood Gorbach; Mary Hilfiker; Addison K May; Avery B Nathens; Robert G Sawyer; John G Bartlett Journal: Surg Infect (Larchmt) Date: 2010-02 Impact factor: 2.150
Authors: J Haijanen; S Sippola; J Grönroos; T Rautio; P Nordström; T Rantanen; M Aarnio; I Ilves; S Hurme; H Marttila; J Virtanen; A Mattila; H Paajanen; P Salminen Journal: BMC Surg Date: 2018-12-17 Impact factor: 2.102
Authors: David A Talan; Gregory J Moran; Anusha Krishnadasan; Sarah E Monsell; Brett A Faine; Lisandra Uribe; Amy H Kaji; Daniel A DeUgarte; Wesley H Self; Nathan I Shapiro; Joseph Cuschieri; Jacob Glaser; Pauline K Park; Thea P Price; Nicole Siparsky; Sabrina E Sanchez; David A Machado-Aranda; Jesse Victory; Patricia Ayoung-Chee; William Chiang; Joshua Corsa; Heather L Evans; Lisa Ferrigno; Luis Garcia; Quinton Hatch; Marc D Horton; Jeffrey Johnson; Alan Jones; Lillian S Kao; Anton Kelly; Daniel Kim; Matthew E Kutcher; Mike K Liang; Nima Maghami; Karen McGrane; Elizaveta Minko; Cassandra Mohr; Miriam Neufeld; Joe H Patton; Colin Rog; Amy Rushing; Amber K Sabbatini; Matthew Salzberg; Callie M Thompson; Aleksandr Tichter; Jon Wisler; Bonnie Bizzell; Erin Fannon; Sarah O Lawrence; Emily C Voldal; Danielle C Lavallee; Bryan A Comstock; Patrick J Heagerty; Giana H Davidson; David R Flum; Larry G Kessler Journal: JAMA Netw Open Date: 2022-07-01
Authors: Sanja Vanhatalo; Eveliina Munukka; Teemu Kallonen; Suvi Sippola; Juha Grönroos; Jussi Haijanen; Antti J Hakanen; Paulina Salminen Journal: PLoS One Date: 2022-10-14 Impact factor: 3.752